Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Cipher Pharmaceuticals Inc. (T.CPH) had Normalized Income after Taxes of 34.66M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
34.66M |
|
-- |
|
-- |
|
-- |
|
14.38M |
|
-- |
|
14.94M |
|
14.94M |
|
34.66M |
|
34.66M |
|
34.66M |
|
|
Normalized Income after Taxes |
34.66M |
14.38M |
|
15.67M |
|
25.38M |
|
25.80M |
|
1.37 |
|
1.34 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
96.00M |
|
-- |
|
-- |
|
-- |
|
12.62M |
|
83.38M |
|
59.36M |
|
83.38M |
|
25.06M |
|
| Cash Flow Statement Financials | |
13.76M |
|
-0.11M |
|
-2.49M |
|
26.74M |
|
37.52M |
|
10.78M |
|
0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.07 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
80.69% |
|
53.45% |
|
53.45% |
|
58.23% |
|
55.52% |
|
128.83% |
|
13.65M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
1.85 |
|
3.04 |
|
120.08 |
|
41.57% |
|
58.39% |
|
36.10% |
|
41.36% |
|
3.33 |
|
0.53 |
|
0.53 |
|